Department of Neurology, Memory and Aging Center, University of California, San Francisco (UCSF), San Francisco, CA 94143, USA.
Acta Neuropathol Commun. 2013 Dec 12;1:80. doi: 10.1186/2051-5960-1-80.
A novel point mutation resulting in a glutamate-to-glycine substitution in PRNP at codon 200, E200G with codon 129 MV polymorphism (cis valine) and type 2 PrPSc was identified in a patient with a prolonged disease course leading to pathology-proven Jakob-Creutzfeldt disease. Despite the same codon as the most common genetic form of human PRNP mutation, E200K, this novel mutation (E200G) presented with a different clinical and pathological phenotype, including prolonged duration, large vacuoles, no vacuolation in the hippocampus, severe neuronal loss in the thalamus, mild cerebellar involvement, and abundant punctate linear and curvilinear deposition of PrPSc in synaptic boutons and axonal terminals along the dendrites.
在一位疾病病程延长的朊病毒病患者中,发现了一种新型点突变,PRNP 第 200 位密码子的谷氨酸突变为甘氨酸(E200G),同时伴有 129 位密码子 MV 多态性(顺式缬氨酸)和 2 型 PrPSc。尽管与人类 PRNP 突变最常见的遗传形式 E200K 相同,但这种新型突变(E200G)表现出不同的临床和病理表型,包括疾病病程延长、大空泡、海马无空泡、丘脑神经元严重丢失、小脑轻度受累以及突触小泡和树突轴突末梢中丰富的点状线性和曲线形 PrPSc 沉积。